Nurse Practitioner · Boston, MA
NPI
1700450301
Since 2021
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
55 Fruit St
Boston, MA, 02114
Phone (617) 724-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,646
99 services
Medicare patients, 2024
34
Average age 72
Drug cost, 2024
$455K
263 prescriptions
Company payments, 2025
$110
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary N DO was code 99214 (office e&m - established), 59 times for 26 patients. In total Mary N DO billed 99 services in 4 codes, and Medicare paid $5,646.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 59 | 26 | $70.32 | $4,149 |
| 99213 Office E&M - Established | Facility | 24 | 15 | $49.48 | $1,188 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 14 | 12 | $12.39 | $173 |
By year: 2022 $1,083 for 24 services; 2023 $61K for 889 services; 2024 $5,646 for 99 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mary N DO prescribed most often to Medicare patients was Letrozole, with 28 prescriptions and refills. In total Mary N DO wrote 263 Medicare prescriptions that cost $455K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 28 | 55 | 12 | $1,337 |
| Loperamide Loperamide Hcl | 16 | 16 | Under 11 | $211 |
| Xermelo Telotristat Etiprate | 15 | 15 | Under 11 | $140K |
| Prochlorperazine Maleate Generic | 14 | 14 | Under 11 | $148 |
| Eliquis Apixaban | 13 | 13 | Under 11 | $7,908 |
| Imatinib Mesylate Generic | 12 | 12 | Under 11 | $7,035 |
| Dexamethasone Generic | 12 | 14 | Under 11 | $69.23 |
| Creon Lipase/Protease/Amylase | 11 | 13 | Under 11 | $14K |
Brand drugs: - claims; generic drugs: 193 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mary N DO $110 ($110 in general payments such as food, travel and fees) from 1 company. The largest payer was Exelixis Inc. with $110.
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. EXEL | 1 | $110 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.